Loading...
Header Logo
Keywords
Last Name
Institution

Dr Eltahir Awad Gasim Khalil

Title• Professor
InstitutionInstitute of Endemic Diseases
DepartmentClinical Pathology & Immunology
AddressQasr Street
Khartoum, 11111
Sudan
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    A graduate of the Faculty of Medicine, University of Khartoum. Post graduate training in hematology, United Kingdom.
    * Professor of Hematology & Immunology, Institute of Endemic Diseases, University of Khartoum.
    * Director, Field & Research Stations, Institute of Endemic Diseases, University of Khartoum.
    Previous Posts:
    * Director, Institute of Endemic Diseases, University of Khartoum
    * Director General, Central Laboratory, Ministry of Science & Technology, Sudan


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wasunna M, Musa A, Hailu A, Khalil EA, Olobo J, Juma R, Wells S, Alvar J, Balasegaram M. The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2016 06; 110(6):321-3. PMID: 27268714.
      View in: PubMed
    2. Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, Abuzaid AA, Dorlo TP, Hurissa Z, Yifru S, Haleke W, Smith PG, Ellis S, Balasegaram M, EL-Hassan AM, Schoone GJ, Wasunna M, Kimutai R, Edwards T, Hailu A. Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis. 2014; 8(1):e2613. PMID: 24454970.
      View in: PubMed
    3. Shakak AO, Khalil EA, Musa AM, Salih KA, Bashir AE, Ahmed AH, Idris FE, Elhassan AM. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-? release assay and tuberculin skin test. BMC Public Health. 2013 Dec 05; 13:1128. PMID: 24313987.
      View in: PubMed
    4. Meheus F, Abuzaid AA, Baltussen R, Younis BM, Balasegaram M, Khalil EAG, Boelaert M, Musa AM. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs. Am J Trop Med Hyg. 2013 Dec; 89(6):1146-1153. PMID: 24189368.
      View in: PubMed
    5. Enan KA, Nabeshima T, Kubo T, Buerano CC, El Hussein AR, Elkhidir IM, Khalil EA, Morita K. Survey of causative agents for acute respiratory infections among patients in Khartoum-State, Sudan, 2010-2011. Virol J. 2013 Oct 25; 10:312. PMID: 24160894.
      View in: PubMed
    6. Musa AM, Khalil EA, Younis BM, Elfaki ME, Elamin MY, Adam AO, Mohamed HA, Dafalla MM, Abuzaid AA, El-Hassan AM. Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan. J Trop Med. 2013; 2013:708391. PMID: 23690794.
      View in: PubMed
    7. Khalil EA, Khidir SA, Musa AM, Musa BY, Elfaki ME, Elkadaru AM, Zijlstra E, El-Hassan AM. Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients. J Trop Med. 2013; 2013:275253. PMID: 23634148.
      View in: PubMed
    8. El Hassan AM, Khalil EA, Elamin WM, El Hassan LA, Ahmed ME, Musa AM. Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis. Case Rep Med. 2013; 2013:351579. PMID: 23533426.
      View in: PubMed
    9. Elfaki ME, Khalil EA, De Groot AS, Musa AM, Gutierrez A, Younis BM, Salih KA, El-Hassan AM. Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines. Hum Vaccin Immunother. 2012 Dec 01; 8(12):1769-74. PMID: 22922767.
      View in: PubMed
    10. Musa A, Khalil E, Hailu A, Olobo J, Balasegaram M, Omollo R, Edwards T, Rashid J, Mbui J, Musa B, Abuzaid AA, Ahmed O, Fadlalla A, El-Hassan A, Mueller M, Mucee G, Njoroge S, Manduku V, Mutuma G, Apadet L, Lodenyo H, Mutea D, Kirigi G, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tafes H, Mekonnen Y, Makonnen E, Ndegwa S, Sagaki P, Kimutai R, Kesusu J, Owiti R, Ellis S, Wasunna M. Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial. PLoS Negl Trop Dis. 2012; 6(6):e1674. PMID: 22724029.
      View in: PubMed
    11. Elzupir AO, Abas AR, Fadul MH, Modwi AK, Ali NM, Jadian AF, Ahmed NA, Adam SY, Ahmed NA, Khairy AA, Khalil EA. Aflatoxin M1 in breast milk of nursing Sudanese mothers. Mycotoxin Res. 2012 May; 28(2):131-4. PMID: 23606051.
      View in: PubMed
    12. Fakiola M, Miller EN, Fadl M, Mohamed HS, Jamieson SE, Francis RW, Cordell HJ, Peacock CS, Raju M, Khalil EA, Elhassan A, Musa AM, Silveira F, Shaw JJ, Sundar S, Jeronimo SM, Ibrahim ME, Blackwell JM. Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J Infect Dis. 2011 Aug 01; 204(3):467-77. PMID: 21742847.
      View in: PubMed
    13. Omollo R, Alexander N, Edwards T, Khalil EA, Younis BM, Abuzaid AA, Wasunna M, Njoroge N, Kinoti D, Kirigi G, Dorlo TP, Ellis S, Balasegaram M, Musa AM. Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Jun 30; 12:166. PMID: 21718522.
      View in: PubMed
    14. Khalil EA, Musa AM, Younis BM, Elfaki ME, Zijlstra EE, Elhassan AM. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication. Trop Doct. 2011 Jul; 41(3):139-40. PMID: 21676981.
      View in: PubMed
    15. Khalil EA, Elnour AA, Musa AM, Elagib AA, Hassab Elgawi SH, Ismail WM, Elzaki KE. Tuberculous lymphadenitis: skin delayed-type hypersensitivity reaction and cellular immune responses. West Afr J Med. 2011 May-Jun; 30(3):193-6. PMID: 22120485.
      View in: PubMed
    16. Edwards T, Omollo R, Khalil EA, Yifru S, Musa B, Musa A, Wasunna M, Smith PG, Royce C, Ellis S, Balasegaram M, Hailu A. Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Mar 06; 12:66. PMID: 21375777.
      View in: PubMed
    17. Omer S, Khalil E, Ali H, Sharief A. Submicroscopic and multiple plasmodium falciparum infections in pregnant Sudanese women. N Am J Med Sci. 2011 Mar; 3(3):137-41. PMID: 22540079.
      View in: PubMed
    18. Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, Wasunna M, Hailu A, Edwards T, Omollo R, Mudawi M, Kokwaro G, El-Hassan A, Khalil E. Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e855. PMID: 21049063.
      View in: PubMed
    19. Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil E, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e709. PMID: 21049059.
      View in: PubMed
    20. Elnojomi NA, Musa AM, Younis BM, Elfaki ME, El-Hassan AM, Khalil EA. Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. Saudi J Kidney Dis Transpl. 2010 Sep; 21(5):872-5. PMID: 20814123.
      View in: PubMed
    21. Hamad SH, Khalil EA, Musa AM, Ibrahim ME, Younis BM, Elfaki ME, El-Hassan AM. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD. Exp Parasitol. 2010 Aug; 125(4):389-93. PMID: 20346944.
      View in: PubMed
    22. Salih NA, Hussain AA, Almugtaba IA, Elzein AM, Elhassan IM, Khalil EA, Ishag HB, Mohammed HS, Kwiatkowski D, Ibrahim ME. Loss of balancing selection in the betaS globin locus. BMC Med Genet. 2010 Feb 03; 11:21. PMID: 20128890.
      View in: PubMed
    23. Farouk S, Salih MA, Musa AM, Blackwell JM, Miller EN, Khalil EA, Elhassan AM, Ibrahim ME, Mohamed HS. Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population. Public Health Genomics. 2010; 13(6):362-7. PMID: 20051670.
      View in: PubMed
    24. Musa AM, Noazin S, Khalil EA, Modabber F. Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. Trans R Soc Trop Med Hyg. 2010 Jan; 104(1):1-2. PMID: 19712953.
      View in: PubMed
    25. Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis. Vaccine. 2009 Jul 30; 27(35):4747-53. PMID: 19540273.
      View in: PubMed
    26. Nimir AA, Khalil EA, Musa AM, Yassin HM, El-Hassan AM. Evaluation of the particle gel diffusion technique for the detection of haemoglobin S in Sudanese patients. Ann Clin Biochem. 2009 Mar; 46(Pt 2):114-6. PMID: 19164340.
      View in: PubMed
    27. Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 09; 26(52):6759-67. PMID: 18950671.
      View in: PubMed
    28. Elagib AH, Ahmed AE, Hussein A, Musa AM, Khalil EA, El-Hassan AM. Possible predisposing factors for thrombotic cerebrovascular accidents in Sudanese patients. Saudi Med J. 2008 Feb; 29(2):304-6. PMID: 18246249.
      View in: PubMed
    29. Khalil EA, Musa AM, Elgawi SH, Meshasha A, Gamar Eldawla I, Elhassan MO, Eljaleel KA, Younis BM, Elfaki ME, El-Hassan AM. Revival of a focus of visceral leishmaniasis in central Sudan. Ann Trop Med Parasitol. 2008 Jan; 102(1):79-80. PMID: 18186981.
      View in: PubMed
    30. Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg. 2008 Jan; 102(1):58-63. PMID: 17963805.
      View in: PubMed
    31. Sharief AH, Khalil EA, Omer SA, Abdalla HS. Innovative serum-free medium for in vitro cultivation of promastigote forms of Leishmania species. Parasitol Int. 2008 Jun; 57(2):138-42. PMID: 18024187.
      View in: PubMed
    32. Miller EN, Fadl M, Mohamed HS, Elzein A, Jamieson SE, Cordell HJ, Peacock CS, Fakiola M, Raju M, Khalil EA, Elhassan A, Musa AM, Ibrahim ME, Blackwell JM. Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet. 2007 May 11; 3(5):e71. PMID: 17500593.
      View in: PubMed
    33. Sharafeldin GS, Khalil EA, El Hag IA, Elsiddig KE, Elsafi ME, Aijafari AS, Elnour AA, Hussein AM, Elkhidir IM, El-Hassan AM. Haematogenous dissemination of tuberculous lymphadenitis. East Afr Med J. 2007 Jan; 84(1):3-7. PMID: 17633578.
      View in: PubMed
    34. Khalil EA, Musa AM, Modabber F, El-Hassan AM. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study. Ann Trop Paediatr. 2006 Dec; 26(4):357-61. PMID: 17132302.
      View in: PubMed
    35. Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EA, ElHassan AM, Musa AM, Mohamed HS. IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun. 2007 Jan; 8(1):75-8. PMID: 17136124.
      View in: PubMed
    36. Ismail A, Khalil EA, Musa AM, El Hassan IM, Ibrahim ME, Theander TG, El Hassan AM. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role? Med Hypotheses. 2006; 66(5):993-9. PMID: 16386855.
      View in: PubMed
    37. Khalil EA, Ahmed AE, Musa AM, Hussein MH. Antimony-induced cerebellar ataxia. Saudi Med J. 2006 Jan; 27(1):90-2. PMID: 16432602.
      View in: PubMed
    38. Elamin EM, Guerbouj S, Musa AM, Guizani I, Khalil EA, Mukhtar MM, Elkadaro AM, Mohamed HS, Ibrahim ME, Abdel Hamid MM, El Azhari M, El Hassan AM. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Trans R Soc Trop Med Hyg. 2005 Nov; 99(11):803-8. PMID: 16099005.
      View in: PubMed
    39. Musa AM, Khalil EA, Mahgoub FA, Hamad S, Elkadaru AM, El Hassan AM. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Ann Trop Med Parasitol. 2005 Sep; 99(6):563-9. PMID: 16156969.
      View in: PubMed
    40. Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol. 2005 May; 140(2):349-53. PMID: 15807861.
      View in: PubMed
    41. Khalifa EH, Kaballo BG, Suleiman SM, Khalil EA, El-Hassan AM. Pattern of glomerulonephritis in Sudan: histopathological and immunofluorescence study. Saudi J Kidney Dis Transpl. 2004 Apr-Jun; 15(2):176-9. PMID: 17642773.
      View in: PubMed
    42. Aljafari AS, Khalil EA, Elsiddig KE, El Hag IA, Ibrahim ME, Elsafi ME, Hussein AM, Elkhidir IM, Sulaiman GS, Elhassan AM. Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study. Cytopathology. 2004 Feb; 15(1):44-8. PMID: 14748791.
      View in: PubMed
    43. Mohamed HS, Ibrahim ME, Miller EN, White JK, Cordell HJ, Howson JM, Peacock CS, Khalil EA, El Hassan AM, Blackwell JM. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet. 2004 Jan; 12(1):66-74. PMID: 14523377.
      View in: PubMed
    44. Bereir RE, Mohamed HS, Seielstad M, El Hassani AM, Khalil EA, Peacock CS, Blackwell JM, Ibrahim ME. Allele frequency and genotype distribution of polymorphisms within disease-related genes is influenced by ethnic population sub-structuring in Sudan. Genetica. 2003 Sep; 119(1):57-63. PMID: 12903747.
      View in: PubMed
    45. Mohamed HS, Ibrahim ME, Miller EN, Peacock CS, Khalil EA, Cordell HJ, Howson JM, El Hassan AM, Bereir RE, Blackwell JM. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun. 2003 Jul; 4(5):351-5. PMID: 12847550.
      View in: PubMed
    46. Abdo MG, Elamin WM, Khalil EA, Mukhtar MM. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation. East Mediterr Health J. 2003 Jul; 9(4):837-43. PMID: 15748080.
      View in: PubMed
    47. Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Trans R Soc Trop Med Hyg. 2003 May-Jun; 97(3):365-8. PMID: 15228261.
      View in: PubMed
    48. Elsiddig KE, Khalil EA, Elhag IA, Elsafi ME, Suleiman GM, Elkhidir IM, Hussein AM, El-Hassan AM. Granulomatous mammary disease: ten years' experience with fine needle aspiration cytology. Int J Tuberc Lung Dis. 2003 Apr; 7(4):365-9. PMID: 12729342.
      View in: PubMed
    49. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003 Feb; 3(2):87-98. PMID: 12560194.
      View in: PubMed
    50. Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, Mukhtar MM, El Hassan AM. The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol. 2002 Dec; 96(8):765-72. PMID: 12625930.
      View in: PubMed
    51. el Hassan LA, Khalil EA, el-Hassan AM. Socio-cultural aspects of leprosy among the Masalit and Hawsa tribes in the Sudan. Lepr Rev. 2002 Mar; 73(1):20-8. PMID: 11969123.
      View in: PubMed
    52. Khalil EA, Zijlstra EE, Kager PA, El Hassan AM. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health. 2002 Jan; 7(1):35-44. PMID: 11851953.
      View in: PubMed
    53. El Hassan AM, Khalil EA. Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan? Trop Med Int Health. 2001 Sep; 6(9):743-4. PMID: 11555443.
      View in: PubMed
    54. Satti IN, Osman HY, Daifalla NS, Younis SA, Khalil EA, Zijlstra EE, El Hassan AM, Ghalib HW. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers. Vaccine. 2001 Feb 28; 19(15-16):2100-6. PMID: 11228382.
      View in: PubMed
    55. Cavanagh DR, Dobaño C, Elhassan IM, Marsh K, Elhassan A, Hviid L, Khalil EA, Theander TG, Arnot DE, McBride JS. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun. 2001 Feb; 69(2):1207-11. PMID: 11160024.
      View in: PubMed
    56. Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health. 2001 Feb; 6(2):108-13. PMID: 11251906.
      View in: PubMed
    57. Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 2000 Nov 04; 356(9241):1565-9. PMID: 11075771.
      View in: PubMed
    58. Khalil EA, Elhassan AM, Zijlstra EE, Osman OF, Eljack IA, Ibrahim ME, Mukhtar MM, Ghalib HW, Modabbers F. Safety and immunogenicity of an autoclaved Leishmania major vaccine. East Afr Med J. 2000 Sep; 77(9):468-70. PMID: 12862135.
      View in: PubMed
    59. Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol. 2000 Jul; 143(1):136-43. PMID: 10886148.
      View in: PubMed
    60. Gasim S, Elhassan AM, Kharazmi A, Khalil EA, Ismail A, Theander TG. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC). Clin Exp Immunol. 2000 Mar; 119(3):523-9. PMID: 10691926.
      View in: PubMed
    61. Khalil EA, Elsiddig KE, Elsafi ME, el-Hag IA, Elkhidir IM, Suleiman G, Hussein AM, Ibrahim ME, el-Hassan AM. Supra-sternal notch tuberculous abscess: a report of three cases. Trans R Soc Trop Med Hyg. 2000 Jan-Feb; 94(1):58-60. PMID: 10748902.
      View in: PubMed
    62. Ibrahim ME, Lambson B, Yousif AO, Deifalla NS, Alnaiem DA, Ismail A, Yousif H, Ghalib HW, Khalil EA, Kadaro A, Barker DC, El Hassan AM. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg. 1999 Dec; 61(6):941-4. PMID: 10674674.
      View in: PubMed
    63. Zijlstra EE, Daifalla NS, Kager PA, Khalil EA, El-Hassan AM, Reed SG, Ghalib HW. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol. 1998 Sep; 5(5):717-20. PMID: 9729541.
      View in: PubMed
    64. el Hassan AM, Khalil EA, el Sheikh EA, Zijlstra EE, Osman A, Ibrahim ME. Post kala-azar ocular leishmaniasis. Trans R Soc Trop Med Hyg. 1998 Mar-Apr; 92(2):177-9. PMID: 9764325.
      View in: PubMed
    65. Saeed AM, Khalil EA, Elhassan AM, Hashim FA, Elhassan AM, Fandrey J, Jelkmann W. Serum erythropoietin concentration in anaemia of visceral leishmaniasis (kala-azar) before and during antimonial therapy. Br J Haematol. 1998 Mar; 100(4):720-4. PMID: 9531339.
      View in: PubMed
    66. Khalil EA, el Hassan AM, Zijlstra EE, Hashim FA, Ibrahim ME, Ghalib HW, Ali MS. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann Trop Med Parasitol. 1998 Mar; 92(2):151-8. PMID: 9625910.
      View in: PubMed
    67. Staalsø T, Khalil EA, Elhassan IM, Zijlstra EE, Elhassan AM, Giha HA, Theander TG, Jakobsen PH. Antibody reactivity to conserved linear epitopes of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). Immunol Lett. 1998 Feb; 60(2-3):121-6. PMID: 9557953.
      View in: PubMed
    68. Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, Kharazmi A, Theander TG. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol. 1998 Jan; 111(1):64-9. PMID: 9472662.
      View in: PubMed
    69. Andresen K, Gasim S, Elhassan AM, Khalil EA, Barker DC, Theander TG, Kharazmi A. Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Trop Med Int Health. 1997 May; 2(5):440-4. PMID: 9217699.
      View in: PubMed
    70. el Hassan AM, Kadaru AM, Khalil EA, Fadl A, el Hassan MM. The pathology of cutaneous leishmaniasis in the Sudan: a comparison with that in other geographical areas. Ann Trop Med Parasitol. 1996 Oct; 90(5):485-90. PMID: 8915124.
      View in: PubMed
    71. Gaafar A, Ismail A, el Kadaro AY, Hashim E, Khalil EA, el Hassan AM. Necrotizing and suppurative lymphadenitis in Leishmania major infections. Trop Med Int Health. 1996 Apr; 1(2):243-50. PMID: 8665392.
      View in: PubMed
    72. Khalil EA, Nur NM, Zijlstra EE, El-Hassan AM, Davidson RN. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg. 1996 Mar-Apr; 90(2):187-8. PMID: 8761586.
      View in: PubMed
    73. el-Hassan AM, Meredith SE, Yagi HI, Khalil EA, Ghalib HW, Abbas K, Zijlstra EE, Kroon CC, Schoone GJ, Ismail A. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans R Soc Trop Med Hyg. 1995 Nov-Dec; 89(6):647-52. PMID: 8594683.
      View in: PubMed
    74. Hashim FA, Khalil EA, Ismail A, el Hassan AM. Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B. Trans R Soc Trop Med Hyg. 1995 Jul-Aug; 89(4):440. PMID: 7570893.
      View in: PubMed
    Khalil's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _